CCDC157
gene geneOn this page
Summary
CCDC157 (coiled-coil domain containing 157, HGNC:33854) is a protein-coding gene on chromosome 22q12.2, encoding Coiled-coil domain-containing protein 157 (Q569K6).
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 172 total
- MANE Select transcript:
NM_001017437
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33854 |
| Approved symbol | CCDC157 |
| Name | coiled-coil domain containing 157 |
| Location | 22q12.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000187860 |
| Ensembl biotype | protein_coding |
| OMIM | 619391 |
| Entrez | 550631 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 6 protein_coding, 2 retained_intron
ENST00000338306, ENST00000399824, ENST00000405659, ENST00000430839, ENST00000445005, ENST00000475975, ENST00000482413, ENST00000943832
RefSeq mRNA: 3 — MANE Select: NM_001017437
NM_001017437, NM_001318334, NM_001318335
CCDS: CCDS33632, CCDS82707
Canonical transcript exons
ENST00000338306 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001368261 | 30371650 | 30371727 |
| ENSE00001369826 | 30370326 | 30370950 |
| ENSE00001388550 | 30375479 | 30375663 |
| ENSE00001491876 | 30361961 | 30362114 |
| ENSE00001491878 | 30357007 | 30357132 |
| ENSE00001611097 | 30365990 | 30366248 |
| ENSE00003470716 | 30373923 | 30374091 |
| ENSE00003513029 | 30373597 | 30373764 |
| ENSE00003517184 | 30369432 | 30369603 |
| ENSE00003517459 | 30376433 | 30378673 |
| ENSE00003596583 | 30372075 | 30372286 |
| ENSE00003624876 | 30376259 | 30376347 |
Expression profiles
Bgee: expression breadth ubiquitous, 171 present calls, max score 92.08.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.9053 / max 96.5322, expressed in 1282 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 191675 | 1.2398 | 608 |
| 191674 | 1.0472 | 614 |
| 191673 | 0.5159 | 238 |
| 191676 | 0.0785 | 24 |
| 191677 | 0.0238 | 3 |
Top tissues by expression
240 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 92.08 | gold quality |
| left testis | UBERON:0004533 | 89.28 | gold quality |
| right testis | UBERON:0004534 | 89.22 | gold quality |
| buccal mucosa cell | CL:0002336 | 89.16 | gold quality |
| sperm | CL:0000019 | 87.33 | silver quality |
| testis | UBERON:0000473 | 85.75 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 80.78 | gold quality |
| cortical plate | UBERON:0005343 | 78.98 | gold quality |
| oocyte | CL:0000023 | 77.80 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.17 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 76.20 | silver quality |
| ventricular zone | UBERON:0003053 | 75.14 | gold quality |
| adenohypophysis | UBERON:0002196 | 75.07 | gold quality |
| prefrontal cortex | UBERON:0000451 | 74.89 | gold quality |
| tibialis anterior | UBERON:0001385 | 74.22 | silver quality |
| granulocyte | CL:0000094 | 74.14 | gold quality |
| pituitary gland | UBERON:0000007 | 73.82 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 73.49 | gold quality |
| hypothalamus | UBERON:0001898 | 73.35 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 73.00 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 72.93 | gold quality |
| metanephros cortex | UBERON:0010533 | 72.82 | gold quality |
| secondary oocyte | CL:0000655 | 72.58 | gold quality |
| right frontal lobe | UBERON:0002810 | 72.57 | gold quality |
| bronchial epithelial cell | CL:0002328 | 72.44 | gold quality |
| nucleus accumbens | UBERON:0001882 | 72.18 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 72.10 | gold quality |
| thyroid gland | UBERON:0002046 | 72.09 | gold quality |
| neocortex | UBERON:0001950 | 71.88 | gold quality |
| ganglionic eminence | UBERON:0004023 | 71.68 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.97 |
| E-CURD-112 | yes | 7.97 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
66 targeting CCDC157, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-6888-3P | 99.97 | 65.95 | 1170 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-4731-5P | 99.89 | 67.23 | 2537 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
| HSA-MIR-6733-5P | 99.74 | 67.94 | 2759 |
| HSA-MIR-24-3P | 99.59 | 69.97 | 1934 |
| HSA-MIR-4472 | 99.56 | 66.08 | 1478 |
| HSA-MIR-3153 | 99.55 | 67.59 | 2337 |
| HSA-MIR-4489 | 99.50 | 65.56 | 785 |
| HSA-MIR-5584-5P | 99.49 | 68.22 | 2814 |
| HSA-MIR-4677-3P | 99.49 | 67.91 | 1246 |
| HSA-MIR-4498 | 99.47 | 67.42 | 2360 |
| HSA-MIR-4316 | 99.37 | 65.75 | 1360 |
| HSA-MIR-504-3P | 99.30 | 67.18 | 1745 |
| HSA-MIR-3692-5P | 99.29 | 67.04 | 1421 |
| HSA-MIR-4641 | 99.28 | 66.64 | 744 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-149-5P | 99.25 | 67.16 | 1315 |
| HSA-MIR-4727-5P | 99.23 | 67.55 | 1154 |
| HSA-MIR-5787 | 99.22 | 67.86 | 2628 |
Literature-anchored findings (GeneRIF, showing 2)
- The CCDC157 is localized along the secretory pathway and was found to interact with resident proteins of ER-Golgi membranes. (PMID:31488582)
- CCDC157 is essential for sperm differentiation and shows oligoasthenoteratozoospermia-related mutations in men. (PMID:38509755)
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ccdc157 | ENSDARG00000056279 |
| mus_musculus | Ccdc157 | ENSMUSG00000051427 |
| rattus_norvegicus | Ccdc157 | ENSRNOG00000005147 |
| drosophila_melanogaster | SMC3 | FBGN0015615 |
| caenorhabditis_elegans | WBGENE00004873 | |
| caenorhabditis_elegans | WBGENE00012198 | |
| caenorhabditis_elegans | WBGENE00019087 |
Paralogs (7): SMC1A (ENSG00000072501), SMC1B (ENSG00000077935), SMC3 (ENSG00000108055), SMC4 (ENSG00000113810), CKAP4 (ENSG00000136026), SMC2 (ENSG00000136824), CCDC122 (ENSG00000151773)
Protein
Protein identifiers
Coiled-coil domain-containing protein 157 — Q569K6 (reviewed: Q569K6)
All UniProt accessions (4): A8MUK5, E7ETG3, E7EWT0, Q569K6
UniProt curated annotations — full annotation on UniProt →
RefSeq proteins (3): NP_001017437, NP_001305263, NP_001305264 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029681 | CCDC157 | Family |
UniProt features (16 total): compositionally biased region 5, region of interest 4, sequence variant 3, coiled-coil region 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q569K6-F1 | 72.73 | 0.47 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 60 (showing top):
GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN, DODD_NASOPHARYNGEAL_CARCINOMA_DN, GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP, CHAF1B_TARGET_GENES, FOXJ2_TARGET_GENES, FOXN3_TARGET_GENES, ZNF610_TARGET_GENES, MIR5584_5P, MIR4447, MIR5196_5P, MIR4747_5P, MIR4505, MIR5787, MIR24_3P, MIR6778_3P
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
260 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CCDC157 | RNF215 | Q9Y6U7 | 419 |
| CCDC157 | TLCD5 | Q6ZRR5 | 380 |
| CCDC157 | C10orf88 | Q9H8K7 | 374 |
| CCDC157 | TMEM101 | Q96IK0 | 371 |
| CCDC157 | AMZ1 | Q400G9 | 370 |
| CCDC157 | LGALS16 | A8MUM7 | 370 |
| CCDC157 | CCDC171 | Q6TFL3 | 367 |
| CCDC157 | SACK1C | Q9BQN1 | 357 |
| CCDC157 | ZKSCAN4 | Q969J2 | 317 |
| CCDC157 | TTC17 | Q96AE7 | 311 |
| CCDC157 | EIF4EBP3 | O60516 | 306 |
| CCDC157 | LRRC37A | A6NMS7 | 305 |
| CCDC157 | OSCP1 | Q8WVF1 | 305 |
| CCDC157 | LRRC37A3 | O60309 | 303 |
| CCDC157 | WIPF3 | A6NGB9 | 299 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CCDC157 | NFATC2IP | psi-mi:“MI:0915”(physical association) | 0.560 |
| TCEA2 | CCDC157 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC157 | NFATC2IP | psi-mi:“MI:0915”(physical association) | 0.000 |
| TCEA2 | CCDC157 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (7): CCDC157 (Two-hybrid), CCDC157 (Two-hybrid), CCDC157 (Affinity Capture-MS), CCDC157 (Affinity Capture-MS), CCDC157 (Affinity Capture-MS), CCDC157 (Affinity Capture-MS), CCDC157 (Affinity Capture-MS)
ESM2 similar proteins: A1A4V9, A2A8U2, A4IFI1, A8E4X8, B0BMZ6, F1R7R1, G5E8P0, O75161, P12755, P59017, P59240, P85299, P97432, Q14DQ1, Q2HJA5, Q3B7M3, Q3U0L2, Q3ZBK7, Q3ZK22, Q53GS7, Q569K6, Q58DT5, Q5FVG6, Q5RAS2, Q5SNT2, Q5T7N3, Q5XI52, Q60698, Q6NZQ0, Q80U62, Q812A5, Q8C0R7, Q8C190, Q8CC12, Q8IWY9, Q8IYY4, Q8N9B5, Q8NFW9, Q8R1F1, Q8R322
Diamond homologs: A4IFI1, Q569K6, Q5SPX1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
172 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 144 |
| Likely benign | 11 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2384 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:30370317:T:A | acceptor_gain | 1.0000 |
| 22:30373590:T:A | acceptor_gain | 1.0000 |
| 22:30373595:A:AG | acceptor_gain | 1.0000 |
| 22:30373596:G:GA | acceptor_gain | 1.0000 |
| 22:30373596:GT:G | acceptor_gain | 1.0000 |
| 22:30373596:GTC:G | acceptor_gain | 1.0000 |
| 22:30373596:GTCT:G | acceptor_gain | 1.0000 |
| 22:30373731:G:GT | donor_gain | 1.0000 |
| 22:30373761:GCAG:G | donor_gain | 1.0000 |
| 22:30373765:G:GC | donor_loss | 1.0000 |
| 22:30373766:T:G | donor_loss | 1.0000 |
| 22:30375637:G:GT | donor_gain | 1.0000 |
| 22:30375637:G:T | donor_gain | 1.0000 |
| 22:30376257:A:AG | acceptor_gain | 1.0000 |
| 22:30376257:AGCT:A | acceptor_gain | 1.0000 |
| 22:30376258:G:GA | acceptor_gain | 1.0000 |
| 22:30376258:GC:G | acceptor_gain | 1.0000 |
| 22:30376258:GCT:G | acceptor_gain | 1.0000 |
| 22:30376258:GCTG:G | acceptor_gain | 1.0000 |
| 22:30376346:GG:G | donor_gain | 1.0000 |
| 22:30376347:GG:G | donor_gain | 1.0000 |
| 22:30356725:GGTAC:G | donor_loss | 0.9900 |
| 22:30356726:GTAC:G | donor_loss | 0.9900 |
| 22:30356727:TA:T | donor_loss | 0.9900 |
| 22:30356728:A:AT | donor_loss | 0.9900 |
| 22:30366245:ACAGG:A | donor_loss | 0.9900 |
| 22:30366246:CAG:C | donor_loss | 0.9900 |
| 22:30366247:AG:A | donor_loss | 0.9900 |
| 22:30366248:GGTG:G | donor_loss | 0.9900 |
| 22:30366249:G:GC | donor_loss | 0.9900 |
AlphaMissense
4861 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:30366118:T:A | W40R | 0.994 |
| 22:30366118:T:C | W40R | 0.994 |
| 22:30366124:T:C | F42L | 0.993 |
| 22:30366126:C:A | F42L | 0.993 |
| 22:30366126:C:G | F42L | 0.993 |
| 22:30366120:G:C | W40C | 0.992 |
| 22:30366120:G:T | W40C | 0.992 |
| 22:30366236:T:C | L79P | 0.992 |
| 22:30369451:A:C | S90R | 0.992 |
| 22:30369453:C:A | S90R | 0.992 |
| 22:30369453:C:G | S90R | 0.992 |
| 22:30366248:G:T | R83M | 0.991 |
| 22:30366062:T:C | L21P | 0.988 |
| 22:30366123:G:C | K41N | 0.988 |
| 22:30366123:G:T | K41N | 0.988 |
| 22:30366245:A:C | D82A | 0.988 |
| 22:30366248:G:C | R83T | 0.988 |
| 22:30369432:G:C | R83S | 0.986 |
| 22:30369432:G:T | R83S | 0.986 |
| 22:30366053:T:C | L18P | 0.985 |
| 22:30366245:A:T | D82V | 0.985 |
| 22:30366227:T:C | L76P | 0.983 |
| 22:30373611:G:C | K450N | 0.982 |
| 22:30373611:G:T | K450N | 0.982 |
| 22:30366116:C:T | S39F | 0.981 |
| 22:30366121:A:G | K41E | 0.981 |
| 22:30370730:G:C | W275C | 0.980 |
| 22:30370730:G:T | W275C | 0.980 |
| 22:30369434:T:C | L84P | 0.979 |
| 22:30370728:T:A | W275R | 0.979 |
dbSNP variants (sampled 300 via entrez): RS1000078259 (22:30363797 C>T), RS1000471745 (22:30368341 G>A,T), RS1000545210 (22:30368511 C>G,T), RS1000598881 (22:30362518 C>A), RS1000937942 (22:30356181 C>T), RS1001222109 (22:30361960 G>A,C), RS1001322780 (22:30363188 G>A), RS1001377847 (22:30358647 C>T), RS1001411936 (22:30358411 C>T), RS1001484839 (22:30356896 G>A,C), RS1001586005 (22:30363413 G>A,C), RS1001705080 (22:30365073 G>C), RS1001728427 (22:30378818 A>G), RS1002189 (22:30375469 T>A,C,G), RS1002305044 (22:30363611 G>A)
Disease associations
OMIM: gene MIM:619391 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002097_10 | Coronary artery calcification | 9.000000e-06 |
| GCST90002383_105 | Hematocrit | 2.000000e-11 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004723 | coronary artery calcification |
| EFO:0004348 | hematocrit |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
13 total (human), top 13 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | decreases expression, increases abundance, increases expression | 2 |
| Smoke | increases expression, decreases expression, increases abundance | 2 |
| Particulate Matter | increases expression, decreases expression, increases abundance | 2 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | affects expression | 1 |
| beta-lapachone | decreases expression | 1 |
| abrine | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Rotenone | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Cyclosporine | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.